Physician profile
Peter K Boulos
NPI 1013375724
$8,026.55
in general payments reported to CMS, 2019-2025
16 companies · $1,966 in 2025
The $1,966 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.82 · 2021: $332 · 2022: $944 · 2023: $970 · 2024: $3,794 · 2025: $1,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,615 · Food and Beverage: $3,113 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,614.61 |
| Food and Beverage | $3,113.45 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,884.32 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Medtronic, INC. | $1,763.46 | 2022-2024 | Corevalve Evolut R |
| Abbott Laboratories | $1,513.64 | 2021-2025 | Mitraclip, Optis, Assurity |
| Boston Scientific Corporation | $644.48 | 2023-2025 | Watchman, General - Balloon Catheters |
| Astellas Pharma US INC | $353.96 | 2021-2022 | |
| Abiomed | $226.68 | 2024-2025 | Impella |
| Shockwave Medical, INC | $129.12 | 2025 | |
| Asahi Intecc USA, INC. | $122.85 | 2022 | |
| Janssen Pharmaceuticals, INC | $97.22 | 2022 | |
| Chiesi USA, INC. | $86.69 | 2023-2025 | Kengreal |
| W. L. Gore & Associates, INC. | $51.27 | 2024-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.88 | 2022 | |
| Biotronik INC. | $29.33 | 2025 | Orsiro Mission |
| Terumo Medical Corporation | $20.82 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $13.83 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Boulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.